Vas Narasimhan talks to Monocle

Novartis CEO Vas Narasimhan
00:00 min00:00 min

Vas Narasimhan talks to Monocle

The Briefing

Novartis CEO Vas Narasimhan lost no time to refocus the company’s R&D engine on finding scientific solutions for the coronavirus crisis, helped set up emergency health programs and made Novartis the first company to commit to keeping relevant and essential generic medicines cost-stable. Nevertheless, he is warning of a hidden epidemic.

Published on 21/01/2021

More

Thanks for reading Live.Magazine

Stay connected by subscribing to our newsletter

Subscribe

By submitting your email, you consent to Novartis AG collecting and processing your email data for Novartis internal use, in accordance with our privacy policy, and by protected technical means.